* Mesa Laboratories Inc MLAB.OQ MLAB.O is expected
to show a
fall in quarterly revenue when it reports results on May 31 for
the period ending March 31 2024
* The Lakewood Colorado-based company is expected to report
a
0.6% decrease in revenue to $55.275 million from $55.59 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Mesa Laboratories Inc is
for a
loss of 11 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $130.00, above its last closing price of $114.25.
This summary was machine generated May 29 at 12:34 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)